Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Poggi

Showing results (11-20 of 169) with videos related to

Pageof 17
Sort By:
The Indian Journal of Medical Research|April 23, 2015
Mesenchymal stromal cells as regulators of anti-tumour immune responseAlessandro Poggi, M R Zocchi
Current Medicinal Chemistry|December 17, 2011
Targeting the microenvironment in hematological malignancies: how to condition both stromal and effector cells to overcome cancer spreadingMaria Raffaella Zocchi, Alessandro Poggi
Frontiers in Immunology|November 27, 2014
γδ T Lymphocytes as a First Line of Immune Defense: Old and New Ways of Antigen Recognition and Implications for Cancer ImmunotherapyAlessandro Poggi, Maria Raffaella Zocchi
Current Stem Cell Research & Therapy|December 6, 2018
Immunomodulatory Properties of Mesenchymal Stromal Cells: Still Unresolved "Yin and Yang"Alessandro Poggi, Maria R Zocchi
Human Immunology|September 27, 2008
Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cellsAlessandro Poggi, Maria Raffaella Zocchi
Autoimmunity Reviews|April 7, 2007
Human natural killer lymphocytes through the engagement of natural cytotoxicity receptors and NKG2D can trigger self-aggressionAlessandro Poggi, Maria Raffaella Zocchi
Clinical & Developmental Immunology|December 13, 2006
HIV-1 Tat triggers TGF-beta production and NK cell apoptosis that is prevented by pertussis toxin BAlessandro Poggi, Maria Raffaella Zocchi
Frontiers in Bioscience : a Journal and Virtual Library|September 11, 2004
Role of gammadelta T lymphocytes in tumor defenseMaria Raffaella Zocchi, Alessandro Poggi
Molecular Therapy Oncolytics|January 3, 2022
Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challengesAlessandro Poggi, Maria Raffaella Zocchi
Oncoimmunology|February 6, 2014
How to exploit stress-related immunity against Hodgkin's lymphoma: Targeting ERp5 and ADAM sheddasesAlessandro Poggi, Maria Raffaella Zocchi
Pageof 17

Showing results (11-20 of 169) with videos related to

Sort By:
Pageof 17
The Indian Journal of Medical Research|April 23, 2015
Mesenchymal stromal cells as regulators of anti-tumour immune responseAlessandro Poggi, M R Zocchi
Current Medicinal Chemistry|December 17, 2011
Targeting the microenvironment in hematological malignancies: how to condition both stromal and effector cells to overcome cancer spreadingMaria Raffaella Zocchi, Alessandro Poggi
Frontiers in Immunology|November 27, 2014
γδ T Lymphocytes as a First Line of Immune Defense: Old and New Ways of Antigen Recognition and Implications for Cancer ImmunotherapyAlessandro Poggi, Maria Raffaella Zocchi
Current Stem Cell Research & Therapy|December 6, 2018
Immunomodulatory Properties of Mesenchymal Stromal Cells: Still Unresolved "Yin and Yang"Alessandro Poggi, Maria R Zocchi
Human Immunology|September 27, 2008
Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cellsAlessandro Poggi, Maria Raffaella Zocchi
Autoimmunity Reviews|April 7, 2007
Human natural killer lymphocytes through the engagement of natural cytotoxicity receptors and NKG2D can trigger self-aggressionAlessandro Poggi, Maria Raffaella Zocchi
Clinical & Developmental Immunology|December 13, 2006
HIV-1 Tat triggers TGF-beta production and NK cell apoptosis that is prevented by pertussis toxin BAlessandro Poggi, Maria Raffaella Zocchi
Frontiers in Bioscience : a Journal and Virtual Library|September 11, 2004
Role of gammadelta T lymphocytes in tumor defenseMaria Raffaella Zocchi, Alessandro Poggi
Molecular Therapy Oncolytics|January 3, 2022
Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challengesAlessandro Poggi, Maria Raffaella Zocchi
Oncoimmunology|February 6, 2014
How to exploit stress-related immunity against Hodgkin's lymphoma: Targeting ERp5 and ADAM sheddasesAlessandro Poggi, Maria Raffaella Zocchi
Pageof 17